Tyvaso refills

Ended Awarded Last action

Contract number
36C24120N0193
Awardee
Awarding agency
Obligated
$119,315

Award facts

Contract value 18% obligated
$660,237.31 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Tyvaso refills- deobligation -$436,636
Funding Only Action P00001 $15,030
Original award $540,922

About this award

This is a firm fixed price delivery order awarded to United Therapeutics Corp, a small disadvantaged business manufacturer, by the Department of Veterans Affairs (VA) Veterans Health Administration. The order, valued at $660,237.31, is a call against United Therapeutics' pre-existing Blanket Purchase Agreement (BPA) and General Services Administration (GSA) Pharmaceutical and Drugs schedule contract.

The contract provides Tyvaso inhalation solution and related pulmonary arterial hypertension and cancer treatment products, including Remodulin, Orenitram, and Unituxin, to the VA for distribution to veterans nationwide. As a prime contractor, United Therapeutics will deliver these specialty pharmaceuticals directly to VA medical facilities and clinics. This order supports the VA's ongoing efforts to centrally procure and distribute critical treatments to veterans through established contracting vehicles.

Quick answers

Who was awarded contract 36C24120N0193?

36C24120N0193 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 1 (Veterans Health Administration) on December 19, 2019.

How much is contract 36C24120N0193 worth?

The government has obligated $119,315 on 36C24120N0193. Its current value, with exercised options, is $660,237.

Is contract 36C24120N0193 an order under another contract?

Yes. 36C24120N0193 is a BPA call under V797D40275-VA797P15A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24120N0193 competed?

The extent of competition for 36C24120N0193 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award